These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 2629847)

  • 1. Monoclonal antibody production in hollow fiber bioreactors using serum-free medium.
    Heifetz AH; Braatz JA; Wolfe RA; Barry RM; Miller DA; Solomon BA
    Biotechniques; 1989 Feb; 7(2):192-9. PubMed ID: 2629847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new serum-free medium for monoclonal antibody production.
    Wolfe RA; Braatz JA; Miller DA; Heifetz AH
    Biotechniques; 1988 Jan; 6(1):62-7. PubMed ID: 3273394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems.
    Kurkela R; Fraune E; Vihko P
    Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of monoclonal antibody in hollow fiber culture system with serum-free medium.
    Zhou W; Cai S
    Chin J Biotechnol; 1992; 8(1):41-9. PubMed ID: 1457721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A perfusion system for high productivity of monoclonal antibody by hybridoma cells in a CelliGen bioreactor.
    Chen Y
    Chin J Biotechnol; 1992; 8(3):179-86. PubMed ID: 1295598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale production of monoclonal antibodies in defined serum-free media in airlift bioreactors.
    Petrossian A; Cortessis GP
    Biotechniques; 1990 Apr; 8(4):414-22. PubMed ID: 2340179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of hybridoma cells and antibody production in agamma calf serum.
    Torres AR; Healey MC; Johnston AV; McKnight ME
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):206-11. PubMed ID: 1477302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hollow fibre dialysis system for the in vitro production of monoclonal antibodies replacing in vivo production in mice.
    Schönherr OT; van Gelder PT; van Hees PJ; van Os AM; Roelofs HW
    Dev Biol Stand; 1987; 66():211-20. PubMed ID: 3582749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum preparation and methods for the large-scale production of IgG monoclonal antibody.
    Zeng QS; Takeyama H; Kanda S; Irie RF
    Hum Antibodies Hybridomas; 1994; 5(1-2):75-80. PubMed ID: 7858185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
    Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
    Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal NS0 cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber.
    Gramer MJ; Maas J
    Biotechnol Prog; 2003; 19(6):1762-6. PubMed ID: 14656153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale production of murine monoclonal antibodies using hollow fiber bioreactors.
    Evans TL; Miller RA
    Biotechniques; 1988 Sep; 6(8):762-7. PubMed ID: 3273638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody production using a new supermacroporous cryogel bioreactor.
    Nilsang S; Nandakumar KS; Galaev IY; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
    Biotechnol Prog; 2007; 23(4):932-9. PubMed ID: 17590012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms.
    Gramer MJ; Britton TL
    Biotechnol Bioeng; 2002 Aug; 79(3):277-83. PubMed ID: 12115416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hollow-fiber bioreactor systems for large-scale production of murine monoclonal antibodies.
    Evans TL; Miller RA
    Targeted Diagn Ther; 1990; 3():25-43. PubMed ID: 2131012
    [No Abstract]   [Full Text] [Related]  

  • 17. Medium-scale production and purification of monoclonal antibodies in protein-free medium.
    Tarleton RL; Beyer AM
    Biotechniques; 1991 Nov; 11(5):590-3. PubMed ID: 1804247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of monoclonal antibodies in culture.
    Reuveny S; Velez D; Riske F; MacMillan JD; Miller L
    Dev Biol Stand; 1985; 60():185-97. PubMed ID: 3930316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting monoclonal antibody production in culture.
    Reuveny S; Velez D; Macmillan JD; Miller L
    Dev Biol Stand; 1987; 66():169-75. PubMed ID: 3582746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell growth and monoclonal antibody production in the presence of antigen and serum.
    Dandulakis G; Herr JC; Kirwan DJ
    Biotechnol Prog; 1995; 11(5):518-24. PubMed ID: 8546836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.